 |
|
Theophylline Toxic Effects From an Over-the-Counter Asthma Medication
Len Scarpinato, DO;
Dan Purdom, MD
Arch Fam Med. 1993;2(10):1081-1083.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Theophylline benefits and difficulties. Lancet. 1983;2:607-608. Editorial.
PUBMED
2. Herman G, Aynesworth MB. Successful treatment of persistent extreme dyspnea 'status asthmaticus.' J Clin Lab Med. 1937;23:135-148.
3. Woodcock AA, Johnson MA, Geddes DM. Theophylline prescribing, serum concentrations, and toxicity. Lancet. 1983;2:610-613.
PUBMED
4. Sessler CN. Theophylline toxicity: clinical features of 116 consecutive cases. Am J Med. 1990;88:567-576.
PUBMED
5. Rasaiah B. Nonprescription availability of antiasthma drugs. Can Med Assoc J. 1988;138:97-98.
PUBMED
6. Expert Panel of the Management of Asthma. Guidelines for the diagnosis and management of asthma: National Heart, Lung, and Blood Institute National Asthma Education Program. J Allergy Clin Immunol. 1991;88:425-534.
PUBMED
7. Litovitz TL, Holm KC, Clancy C, Schmitz BF, Clark LR, Oderda GM. 1992 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. In press. 8. Kelly HW, Lindley C. Asthma products. In: Handbook of Nonprescription Drugs. 9th ed. Washington, DC: American Pharmaceutical Association; 1990. 9. Olin B, ed. Facts and Comparisons. St Louis, Mo: Facts and Comparisons Inc; 1993. 10. Physician's Desk Reference for Nonprescription Drugs. Montvale, NJ: Medical Economics Data; 1992. 11. Rail TW. Drugs used in the treatment of asthma. In: Gilman AG, Goodman LS, Gilman A, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press Inc; 1990:592-607. 12. Physician's Desk Reference. 47th ed. Montvale, NJ: Medical Economics Data; 1993.
|
